5 drug(s) with this reaction
242 total reports
Skin Exfoliation has been reported as an adverse reaction across 5 drug(s) manufactured by Chattem Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 242 adverse event reports mention skin exfoliation in connection with Chattem Inc products.
This page provides a breakdown of which Chattem Inc drugs are most commonly associated with skin exfoliation, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Chattem Inc drugs have skin exfoliation listed in their FDA adverse event reports, sorted by report count:
In addition to skin exfoliation, the following adverse reactions have been reported across Chattem Inc's drug portfolio:
5 drug(s) manufactured by Chattem Inc have skin exfoliation listed in their FDA adverse event reports: FEXOFENADINE HYDROCHLORIDE, MENTHOL, SELENIUM SULFIDE, CAMPHOR, MENTHOL, FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE.
There are a combined 242 reports of skin exfoliation across 5 Chattem Inc drug(s) in the FDA adverse event database.